Shao-Xing Chen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Shao-Xing Chen

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Wei Sheng Wu Xue Bao = Acta Microbiologica Sinica|December 19, 2006

[Isolation, identification and over- siderophores production of Pseudomonas fluorescens sp-f]Xiang Zhao, Shao-Xing Chen, Zhi-Xiong Xie, et al.

Zhonghua Xin Xue Guan Bing Za Zhi|December 23, 2008

[Incidence of metabolic disorders in patients with essential hypertension and patients with primary aldosteronism]Yan-chun Gong, Rui-Min Guo, Shao-xing Chen, et al.

Zhonghua Xin Xue Guan Bing Za Zhi|January 22, 2008

[Prevalence and risk factors of asymptomatic intracranial vascular stenosis in patients with essential hypertension]Yue-ling DU, Shao-xing Chen, Ya-rong Hu, et al.

Bioconjugate Chemistry|March 17, 2005

Yeast transformation process studied by fluorescence labeling techniqueHu-Zhi Zheng, Hui-Hui Liu, Shao-Xing Chen, et al.

Zhonghua Xin Xue Guan Bing Za Zhi|January 16, 2007

[Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients]Shao-xing Chen, Yue-ling Du, Jin Zhang, et al.

Journal of Zhejiang University. Science. B|February 7, 2009

RNA interference against interleukin-5 attenuates airway inflammation and hyperresponsiveness in an asthma modelShao-xing Chen, Feng-ying Huang, Guang-hong Tan, et al.

Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 31, 2023

Efficacy and safety of sacubitril/allisartan for the treatment of primary hypertension: a phase 2 randomized, double-blind studyJin Zhang, Wei Zhang, Jie Yan, et al.

Zhonghua Xin Xue Guan Bing Za Zhi|December 23, 2008

[A randomized, double-blind, double-dummy study comparing a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg to telmisartan 80 mg in Chinese hypertensive patients who failed to respond adequately to telmisartan 80 mg]Shao-xing Chen, Jin Zhang, Shao-liang Chen, et al.

JACC. Asia|October 7, 2024

Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary HypertensionWei Zhang, Jin Zhang, Jie Yan, et al.

Journal of Hypertension|June 13, 2025

Blood pressure-lowering efficacy of Sacubitril/Allisartan versus Olmesartan in Chinese hypertensive patients with a nondipping blood pressure patternWei Zhang, Jie Yan, Jin Zhang, et al.

Pageof 1

Search research articles

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Wei Sheng Wu Xue Bao = Acta Microbiologica Sinica|December 19, 2006

[Isolation, identification and over- siderophores production of Pseudomonas fluorescens sp-f]Xiang Zhao, Shao-Xing Chen, Zhi-Xiong Xie, et al.

Zhonghua Xin Xue Guan Bing Za Zhi|December 23, 2008

[Incidence of metabolic disorders in patients with essential hypertension and patients with primary aldosteronism]Yan-chun Gong, Rui-Min Guo, Shao-xing Chen, et al.

Zhonghua Xin Xue Guan Bing Za Zhi|January 22, 2008

[Prevalence and risk factors of asymptomatic intracranial vascular stenosis in patients with essential hypertension]Yue-ling DU, Shao-xing Chen, Ya-rong Hu, et al.

Bioconjugate Chemistry|March 17, 2005

Yeast transformation process studied by fluorescence labeling techniqueHu-Zhi Zheng, Hui-Hui Liu, Shao-Xing Chen, et al.

Zhonghua Xin Xue Guan Bing Za Zhi|January 16, 2007

[Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients]Shao-xing Chen, Yue-ling Du, Jin Zhang, et al.

Journal of Zhejiang University. Science. B|February 7, 2009

RNA interference against interleukin-5 attenuates airway inflammation and hyperresponsiveness in an asthma modelShao-xing Chen, Feng-ying Huang, Guang-hong Tan, et al.

Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 31, 2023

Efficacy and safety of sacubitril/allisartan for the treatment of primary hypertension: a phase 2 randomized, double-blind studyJin Zhang, Wei Zhang, Jie Yan, et al.

Zhonghua Xin Xue Guan Bing Za Zhi|December 23, 2008

[A randomized, double-blind, double-dummy study comparing a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg to telmisartan 80 mg in Chinese hypertensive patients who failed to respond adequately to telmisartan 80 mg]Shao-xing Chen, Jin Zhang, Shao-liang Chen, et al.

JACC. Asia|October 7, 2024

Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary HypertensionWei Zhang, Jin Zhang, Jie Yan, et al.

Journal of Hypertension|June 13, 2025

Blood pressure-lowering efficacy of Sacubitril/Allisartan versus Olmesartan in Chinese hypertensive patients with a nondipping blood pressure patternWei Zhang, Jie Yan, Jin Zhang, et al.

Pageof 1